 BOSTON-- BUSINESS WIRE --Gamida Cell Ltd. Nasdaq: GMDA, the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced that members of the management team will present at the following upcoming investor conferences: 